Patterson Joshua F. — SEC Form 4 filings

SEC reporting owner CIK 1805702. 5 Form 4 filings on record with FilingPulse; latest filed 2026-04-16.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-02 to 2026-04-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CG Oncology, Inc. (CGON)See Remarks44
Gamida Cell Ltd. (GMDA)GENERAL COUNSEL11

Form 4 filings — Patterson Joshua F.

FiledFormIssuerReported transactionsSource
2026-04-164CG Oncology, Inc. (CGON)Grant/award (A): 45,266 (derivative) @ $0EDGAR
2025-04-164CG Oncology, Inc. (CGON)Grant/award (A): 119,922 (derivative) @ $0EDGAR
2024-10-074CG Oncology, Inc. (CGON)Grant/award (A): 47,775 (derivative) @ $0EDGAR
2024-05-164CG Oncology, Inc. (CGON)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2024-02-024Gamida Cell Ltd. (GMDA)Grant/award (A): 480,319 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1805702 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →